Literature DB >> 11480879

The definition and meaning of treatment-resistant depression.

H A Sackeim1.   

Abstract

Most patients treated for an episode of unipolar or bipolar major depression are treatment resistant in the sense that the majority do not achieve full remission with the first somatic or psychosocial treatment they receive. Little attention has been given to formalizing criteria for evaluating the nature and extent of treatment resistance, even though determining the adequacy and outcome of prior treatment trials is key in clinical decision making about subsequent treatment. Furthermore, determining the adequacy of prior treatment is essential since substantial evidence indicates that large numbers of depressed patients are undertreated, resulting in prolonged episodes and the appearance of "pseudoresistance." Adequacy of antidepressant treatment trials should be defined in terms of thresholds for the dosage and duration of medication, adherence, and clinical outcome. The Antidepressant Treatment History Form is presented as one method to formalize the evaluation of treatment adequacy and treatment resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11480879

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  248 in total

Review 1.  Ketamine for depression: where do we go from here?

Authors:  Marije Aan Het Rot; Carlos A Zarate; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2012-06-16       Impact factor: 13.382

2.  A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder.

Authors:  Lobna Ibrahim; Nancy Diaz Granados; Libby Jolkovsky; Nancy Brutsche; David A Luckenbaugh; W Joseph Herring; William Z Potter; Carlos A Zarate
Journal:  J Clin Psychopharmacol       Date:  2012-08       Impact factor: 3.153

3.  Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.

Authors:  James W Murrough; Le-Ben Wan; Brian Iacoviello; Katherine A Collins; Carly Solon; Benjamin Glicksberg; Andrew M Perez; Sanjay J Mathew; Dennis S Charney; Dan V Iosifescu; Katherine E Burdick
Journal:  Psychopharmacology (Berl)       Date:  2013-09-11       Impact factor: 4.530

4.  Intrinsic Functional Network Connectivity Is Associated With Clinical Symptoms and Cognition in Late-Life Depression.

Authors:  Jason A Gandelman; Kimberly Albert; Brian D Boyd; Jung Woo Park; Meghan Riddle; Neil D Woodward; Hakmook Kang; Bennett A Landman; Warren D Taylor
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-09-21

5.  Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

Authors:  Kamilla W Miskowiak; Maj Vinberg; Ellen M Christensen; Jens D Bukh; Catherine J Harmer; Hannelore Ehrenreich; Lars V Kessing
Journal:  Neuropsychopharmacology       Date:  2013-12-10       Impact factor: 7.853

6.  Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.

Authors:  Norman Sussman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.

Authors:  Michael Paulzen; Ekkehard Haen; Benedikt Stegmann; Stefan Unterecker; Christoph Hiemke; Gerhard Gründer; Georgios Schoretsanitis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-01       Impact factor: 5.270

8.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

9.  A Glutamate Transporter EAAT1 Gene Variant Influences Amygdala Functional Connectivity in Bipolar Disorder.

Authors:  Sara Poletti; Martina Riberto; Benedetta Vai; Davide Ghiglino; Cristina Lorenzi; Alice Vitali; Silvia Brioschi; Clara Locatelli; Alessandro Serretti; Cristina Colombo; Francesco Benedetti
Journal:  J Mol Neurosci       Date:  2018-08-02       Impact factor: 3.444

Review 10.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.